Randomized, Double-Blind, Placebo-Controlled, Phase I Dose-Escalation Study of Single Dose GHB01L1 in Healthy Volunteers

Trial Profile

Randomized, Double-Blind, Placebo-Controlled, Phase I Dose-Escalation Study of Single Dose GHB01L1 in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Apr 2014

At a glance

  • Drugs Influenza virus delta-NS1 vaccine (Primary)
  • Indications Influenza A virus infections; Influenza virus infections
  • Focus Adverse reactions
  • Sponsors AVIR Green Hills Biotechnology
  • Most Recent Events

    • 14 Jan 2010 Results were presented in the Journal of Infectious Diseases.
    • 09 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Dec 2009 Actual end date (Aug 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top